CRON Stock: Soaring After News of Potential Altria Deal
Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) and the CRON stock are trending today in the cannabis media. This morning, CRON is trading high on the Nasdaq exchange after news surfaced yesterday around a potential deal between ... [Read]
CRON Stock: 3 Reasons to Love Cronos Group in 2018
CRON stock is currently selling for $8.89, up 2.13% on the day. But looking at the Cronos Group (NASDAQ:CRON) (TSX:CRON) stock chart over the last five days, it's clear to see how volatile this stock ... [Read]
The Cronos Group (Among Others) Closes in the Red; Stock Down 9%
Cannabis stock prices are fluctuating today. That isn't terribly surprising, except when you consider that most of the stocks that closed in the red zone today are prominent, well-known companies. For instance, take a look ... [Read]
Ginkgo Bioworks Inks $122 Million Deal with Cronos
Ginkgo Bioworks has inked a $122 million USD deal with Toronto's Cronos Group (TSX:CRON). Ginkgo Bioworks is a startup that turns bacteria into consumer goods, and the partnership will allow the company to apply its ... [Read]
Cronos Enters Supply Agreement with Major Cannabis Producer: Watch Out Aurora
You go, Cronos Group! On Thursday, it was disclosed that Cronos Group and Cura entered into a supply agreement. On the news, the Cronos Group stock moved higher. Why, though? What's so special about this ... [Read]
Cannabis Stock Watch: Canopy Growth, Aphria, and Cronos Group
Cannabis Stock Watch: The cannabis market has been heating up for some time now, but this year has seen some surprising stock performances. Here are some major cannabis brands and how they currently fare in the ... [Read]
Cronos Group Continues to Grow
Cronos Group (NASDAQ:CRON) continues stunning investors with its strong operational and financial performance. The company has reported massive sales growth for the first quarter this year. Its sales grew 473% year over year in the ... [Read]
Cronos Group: Why This Cannabis Stock Plunge Despite Astonishing Revenue Growth
Cronos Group (NASDAQ:CRON) share price plummeted 10% after posting substantial revenue and earnings growth for the final quarter of the last year. Traders blame downgrade from analysts for the dip in price. Canaccord Genuity has ... [Read]
Cronos Group Forms Cross-Border JV With U.S. Cannabis Company
In preparation for the upcoming cannabis legalization in Canada, licensed producer Cronos Group Inc. (TSX-V:CRON) has formed a cross-border joint venture with MM Enterprises USA LLC, a leading U.S. cannabis company with facilities in California, ... [Read]